Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Illumina CLIA lab subscribes to Clarity LIMS to augment existing informatics infrastructure

Published: Sunday, March 03, 2013
Last Updated: Saturday, March 02, 2013
Bookmark and Share
GenoLogics Life Science Software's Clarity LIMS signed under a subscription license agreement by Illumina Clinical Services Laboratory.

GenoLogics Life Science Software, a leading provider of laboratory information management systems (LIMS) designed for today's omics labs, has announced that the Illumina Clinical Services Laboratory has signed a subscription license agreement for Clarity LIMS.  Under the agreement, Clarity LIMS, alongside internally developed systems within the CLIA-certified, CAP-accredited laboratory at Illumina, will be used to support Illumina's TruSight Individual Genome Sequencing (IGS) test.

"In the clinical laboratory environment, informatics tools to support compliance, such as the data and workflow enforcement features offered in Clarity LIMS, are crucial to ensuring high quality throughout the laboratory process," said Marc Laurent, Director of Commercial Services for Illumina. "We are confident that Clarity LIMS will help us to maintain our high quality standards and serve physicians and patients as the demand for our sequencing services grow."

Clarity LIMS is an intuitive lab management system that combines information management essentials for CLIA-certified and other regulated labs with a clear and simple interface. Specifically, Clarity LIMS assists these organizations with workflow enforcement, adherence to standard operating procedures and management of the specific complexities associated with next-generation sequencing (NGS). All of these capabilities can be implemented within a few weeks, making Clarity LIMS unparalleled in the industry.

"We are pleased to be part of the Illumina CLIA laboratory's' robust informatics ecosystem," says Michael Ball, CEO of GenoLogics. "An increasing number of CLIA laboratories are taking advantage of our flexible Clarity LIMS subscription licensing to support the growing sequencing services business."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GenoLogics Raises $8 Million Strategic Financing Round Led by Illumina
An $8 million Series D round of financing led by new investor Illumina, Inc. has been raised by GenoLogics Life Sciences Software Inc.
Saturday, October 22, 2011
University of Glasgow Genomics Facility Selects GenoLogics for Systems Biology Solution
Proteus™ and Geneus™ lab and data management solutions selected by UK Genomics Facility and RASOR.
Friday, November 24, 2006
University of Leuven Selects GenoLogics Solution for Lab and Data Management
Proteus™, the lab and scientific data management solution will be used for proteomics and metabolomics research.
Thursday, November 16, 2006
GenoLogics Targets Translational Medicine, Cancer Research with Partnership Strategy of End-to-End Solutions
GenoLogics kicks off the partnership initiative by demonstrating fully integrated translational research and cancer research solutions.
Tuesday, October 31, 2006
GenoLogics Appoints Don Listwin to Board of Directors
Former no. 2 executive at Cisco Systems joins life sciences software company.
Monday, February 06, 2006
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Atmosphere Acidity Minimised to Preindustrial Levels
Sheet ice study shows acidic pollution of the atmosphere has now almost returned to preindustrial levels.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Culex Mosquitoes Do Not Transmit Zika
A study of the Culex species mosquito appears to show that the species does not transmit Zika virus.
Uncovering Water Bear Resilience
A protein identified in water bears can protect DNA of human cells from lethal doses of radiation damage.
“Sixth Sense” More Than a Feeling
NIH study of rare genetic disorder reveals importance of touch and body awareness.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Potential of New Insect Control Traits in Agriculture
Researchers have discovered a protein that shows promise as an alternate corn rootworm control mechanism.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!